Putting the award page together from the records…
Putting the award page together from the records…
The Mitre Corporation received this contract from Fda Office of Acq Grant Svcs, Food and Drug Administration: $11.69M obligated so far for support- professional: engineering/technical. It runs to 2027-09-29.
Key facts · data as of Oct 22, 2026
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 22, 2026.
Cite this page: SpendQuery, Award 75F40124F80370, data as of Oct 22, 2026, https://spendquery.com/award?id=CONT_AWD_75F40124F80370_7524_75FCMC23D0004_7530
The Mitre Corporation: all federal awards · Department of Health and Human Services: spending · Fda Office of Acq Grant Svcs: what it buys · The follow-on: recompete brief
FOOD AND DRUG ADMINISTRATION (FDA) CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) BIOLOGIC EFFECTIVENESS AND SAFETY (BEST) INNOVATIVE METHODS (IM) PROGRAM COR: BRIAN HIVELY [email protected] 3-WAY COST (REQUIRES CO/CS APPROVAL)
Up for re-bid: ends 2027-09-29. Recompete brief →
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
2 subawards totaling $450.0K (3.8% of what was obligated), as The Mitre Corporation reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| Healtheway, Inc. | $450.0K | 2 | VA | 2025-10-23 | 2025-12-31 |
| Date | To | Amount | For |
|---|---|---|---|
| 2025-10-23 | Healtheway, Inc. | $400.0K | EHEALTH EXCHANGE NETWORK |
| 2025-12-31 | Healtheway, Inc. | $50.0K | EHEALTH HUB TECHNOLOGY COMPONENT |
3 actions since 2024-09-27. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-09-24 | P00002 | Option exercised | $5.06M | FOOD AND DRUG ADMINISTRATION (FDA) CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) BIOLOGIC EFFECTIVENESS AND SAFETY (BEST) INNOVATIVE METHODS (IM) PROGRAM COR: DARREN JANSEN DARREN [email protected] 3-WAY COST (REQUIRES CO/CS APPROVAL) |
| 2025-09-29 | P00001 | Option exercised | $2.91M | FOOD AND DRUG ADMINISTRATION (FDA) CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) BIOLOGIC EFFECTIVENESS AND SAFETY (BEST) INNOVATIVE METHODS (IM) PROGRAM COR: DARREN JANSEN DARREN [email protected] 3-WAY COST (REQUIRES CO/CS APPROVAL) |
| 2024-09-27 | 0 | $3.71M | FOOD AND DRUG ADMINISTRATION (FDA) CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) BIOLOGIC EFFECTIVENESS AND SAFETY (BEST) INNOVATIVE METHODS (IM) PROGRAM COR: BRIAN HIVELY [email protected] 3-WAY COST (REQUIRES CO/CS APPROVAL) |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-22). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗